KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹13 Cr | ₹8.81 Cr | ₹-0.72 Cr | ₹7.03 Cr | ₹1.61 Cr |
What is the latest Cash Flow from Financing Activities ratio of KILITCH DRUGS (INDIA) ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹8.81 Cr |
| Mar2023 | ₹-0.72 Cr |
| Mar2022 | ₹7.03 Cr |
| Mar2021 | ₹1.61 Cr |
How is Cash Flow from Financing Activities of KILITCH DRUGS (INDIA) Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | 50.37 | |
| Mar2024 | ₹8.81 Cr | Positive | |
| Mar2023 | ₹-0.72 Cr | Negative | |
| Mar2022 | ₹7.03 Cr | 335.44 | |
| Mar2021 | ₹1.61 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹549.6 Cr | -6.4% | -10.8% | -1.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -6.4% |
-10.8% |
-1.7% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses